Drug intelligence / Profile preview

Triple Paste

Development stage: Unknown
Lead developer: Advantice Health
Modality: DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
Administration: Topical

Overview

**Triple Paste** is a marketed over-the-counter topical diaper-rash ointment containing **zinc oxide 12.8%** as its sole active ingredient. It is indicated to treat and prevent diaper dermatitis by forming a protective physical barrier over chafed skin, reducing exposure to wetness and irritants. The original ointment also contains a petrolatum-based vehicle with corn starch, lanolin, beeswax, glycerin, bisabolol, cholesterol, and oat kernel extract; these inactive ingredients support barrier formation and skin soothing. It is currently marketed by Advantice Health. ([dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=d457c58d-8239-41c4-999e-d0ba237e3945))

Brand names: Triple Paste

Beyond the preview

Go deeper on Triple Paste.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Triple Paste.

Explore the full profile